Kanecia Obie Zimmerman

Quick facts

Marketed products

• 0.25% Timolol Maleate Gel Forming Solution
• 0.5% Timolol Maleate Gel Forming Solution

Phase 2 pipeline

• Experimental: Paxlovid 15 day dosing
• Experimental: Paxlovid 25 day dosing
• Paxlovid 15 day dosing
• Paxlovid 25 day dosing

Competitive intelligence

For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:

• Kanecia Obie Zimmerman portfolio CI brief
• Kanecia Obie Zimmerman pipeline updates RSS